top of page

NOCDURNA ORAL LYOPHILISATE 25MCG

Product details

Registration number: SIN15461P

Classification: Prescription Only

Active ingredients: Desmopressin acetate 28mcg eqv to desmopressin

Strength: 25mcg

Dosage form: TABLET, ORALLY DISINTEGRATING

Route: SUBLINGUAL

Registrant: FERRING PHARMACEUTICALS PRIVATE LIMITED

ATC code: H01BA02

HSA approval date: 3 April 2018

Manufacturer(s): Catalent UK Swindon Zydis Limited

Manufacturing country/countries: UNITED KINGDOM

What are the HSA registration number and classification for NOCDURNA ORAL LYOPHILISATE 25MCG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN15461P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for NOCDURNA ORAL LYOPHILISATE 25MCG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Desmopressin acetate 28mcg eqv to desmopressin

Strength: 25mcg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for NOCDURNA ORAL LYOPHILISATE 25MCG?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET, ORALLY DISINTEGRATING

Route: SUBLINGUAL

Source for this answer

Who is the recorded registrant for NOCDURNA ORAL LYOPHILISATE 25MCG?

According to the HSA dataset updated 7 August 2026:

Registrant: FERRING PHARMACEUTICALS PRIVATE LIMITED

Source for this answer

Which manufacturers and countries are listed for NOCDURNA ORAL LYOPHILISATE 25MCG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Catalent UK Swindon Zydis Limited

Manufacturing country/countries: UNITED KINGDOM

Source for this answer

Where can I look up NOCDURNA ORAL LYOPHILISATE 25MCG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN15461P or the exact product name NOCDURNA ORAL LYOPHILISATE 25MCG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this NOCDURNA ORAL LYOPHILISATE 25MCG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this NOCDURNA ORAL LYOPHILISATE 25MCG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN15461P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page